Bavarian Nordic
Biopharmaceutical company developing cancer immunotherapies and vaccines against infectious diseases. Learn more
Launch date
Employees
Market cap
€2.5b
Enterprise valuation
€2.2b (Public information from Sep 2024)
Share price
€33.05 BV3.F
Company register number 16271187
Hellerup Capital Region of Denmark (HQ)
Authorizing premium user...